Chlorine in PDB 4xta: Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs
Protein crystallography data
The structure of Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs, PDB code: 4xta
was solved by
A.C.Puhl,
P.Webb,
I.Polikarpov,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.04 /
2.50
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
92.400,
62.120,
117.180,
90.00,
101.02,
90.00
|
R / Rfree (%)
|
21.2 /
27.4
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs
(pdb code 4xta). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs, PDB code: 4xta:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 4xta
Go back to
Chlorine Binding Sites List in 4xta
Chlorine binding site 1 out
of 4 in the Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl501
b:0.7
occ:1.00
|
CL2
|
A:DIF501
|
0.0
|
0.7
|
1.0
|
C2
|
A:DIF501
|
1.7
|
0.3
|
1.0
|
C1
|
A:DIF501
|
2.7
|
0.7
|
1.0
|
C3
|
A:DIF501
|
2.7
|
0.2
|
1.0
|
N1
|
A:DIF501
|
3.0
|
0.9
|
1.0
|
C8
|
A:DIF501
|
3.9
|
1.0
|
1.0
|
O2
|
A:DIF501
|
3.9
|
78.2
|
1.0
|
C6
|
A:DIF501
|
4.0
|
0.6
|
1.0
|
C4
|
A:DIF501
|
4.0
|
0.9
|
1.0
|
O
|
A:ARG288
|
4.1
|
95.1
|
1.0
|
OE2
|
A:GLU295
|
4.1
|
93.5
|
1.0
|
C9
|
A:DIF501
|
4.3
|
0.7
|
1.0
|
N
|
A:ALA292
|
4.5
|
86.3
|
1.0
|
OE1
|
A:GLU295
|
4.5
|
96.7
|
1.0
|
C5
|
A:DIF501
|
4.5
|
0.8
|
1.0
|
CB
|
A:ALA292
|
4.6
|
82.0
|
1.0
|
CA
|
A:ALA292
|
4.6
|
82.8
|
1.0
|
CD
|
A:GLU295
|
4.6
|
94.7
|
1.0
|
C14
|
A:DIF501
|
4.7
|
84.0
|
1.0
|
CB
|
A:GLU291
|
4.8
|
87.4
|
1.0
|
C7
|
A:DIF501
|
4.9
|
99.6
|
1.0
|
C
|
A:ARG288
|
5.0
|
92.2
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 4xta
Go back to
Chlorine Binding Sites List in 4xta
Chlorine binding site 2 out
of 4 in the Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl501
b:0.2
occ:1.00
|
CL4
|
A:DIF501
|
0.0
|
0.2
|
1.0
|
C4
|
A:DIF501
|
1.7
|
0.9
|
1.0
|
C5
|
A:DIF501
|
2.7
|
0.8
|
1.0
|
C3
|
A:DIF501
|
2.7
|
0.2
|
1.0
|
N1
|
A:DIF501
|
3.0
|
0.9
|
1.0
|
O
|
A:ILE326
|
3.2
|
79.5
|
1.0
|
N
|
A:LEU330
|
3.3
|
80.1
|
1.0
|
CA
|
A:LEU330
|
3.4
|
77.0
|
1.0
|
C8
|
A:DIF501
|
3.4
|
1.0
|
1.0
|
CD1
|
A:LEU330
|
3.4
|
72.9
|
1.0
|
CB
|
A:LEU330
|
3.7
|
74.8
|
1.0
|
C9
|
A:DIF501
|
3.7
|
0.7
|
1.0
|
C
|
A:MET329
|
3.7
|
72.3
|
1.0
|
C6
|
A:DIF501
|
4.0
|
0.6
|
1.0
|
C2
|
A:DIF501
|
4.0
|
0.3
|
1.0
|
O
|
A:MET329
|
4.0
|
68.4
|
1.0
|
CD1
|
A:LEU333
|
4.1
|
71.3
|
1.0
|
CG
|
A:LEU330
|
4.1
|
82.2
|
1.0
|
C
|
A:ILE326
|
4.1
|
83.5
|
1.0
|
C7
|
A:DIF501
|
4.2
|
99.6
|
1.0
|
CG2
|
A:ILE326
|
4.2
|
84.8
|
1.0
|
CB
|
A:MET329
|
4.2
|
72.3
|
1.0
|
CA
|
A:ILE326
|
4.5
|
84.2
|
1.0
|
C1
|
A:DIF501
|
4.5
|
0.7
|
1.0
|
CA
|
A:MET329
|
4.5
|
71.0
|
1.0
|
C13
|
A:DIF501
|
4.7
|
85.6
|
1.0
|
C10
|
A:DIF501
|
4.7
|
0.8
|
1.0
|
O
|
A:HOH604
|
4.8
|
61.5
|
1.0
|
C
|
A:LEU330
|
4.8
|
76.6
|
1.0
|
CB
|
A:ILE326
|
4.9
|
88.9
|
1.0
|
CD2
|
A:LEU330
|
4.9
|
92.3
|
1.0
|
CG
|
A:LEU333
|
4.9
|
68.6
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 4xta
Go back to
Chlorine Binding Sites List in 4xta
Chlorine binding site 3 out
of 4 in the Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl501
b:0.2
occ:1.00
|
CL2
|
B:DIF501
|
0.0
|
0.2
|
1.0
|
C2
|
B:DIF501
|
1.7
|
63.4
|
1.0
|
C1
|
B:DIF501
|
2.7
|
64.1
|
1.0
|
C3
|
B:DIF501
|
2.7
|
66.5
|
1.0
|
N1
|
B:DIF501
|
3.1
|
72.1
|
1.0
|
C8
|
B:DIF501
|
3.3
|
79.7
|
1.0
|
C9
|
B:DIF501
|
3.4
|
82.6
|
1.0
|
SD
|
B:MET364
|
3.4
|
0.7
|
1.0
|
CD1
|
B:LEU330
|
3.6
|
76.7
|
1.0
|
CD2
|
B:LEU330
|
3.7
|
78.7
|
1.0
|
C6
|
B:DIF501
|
4.0
|
66.6
|
1.0
|
C4
|
B:DIF501
|
4.0
|
65.4
|
1.0
|
CG
|
B:LEU330
|
4.1
|
74.9
|
1.0
|
CE
|
B:MET364
|
4.1
|
74.8
|
1.0
|
CG2
|
B:VAL339
|
4.2
|
60.6
|
1.0
|
C7
|
B:DIF501
|
4.3
|
82.0
|
1.0
|
C10
|
B:DIF501
|
4.4
|
76.9
|
1.0
|
CG1
|
B:VAL339
|
4.5
|
71.7
|
1.0
|
C5
|
B:DIF501
|
4.5
|
66.8
|
1.0
|
SG
|
B:CYS285
|
4.5
|
0.0
|
1.0
|
CB
|
B:VAL339
|
4.9
|
74.1
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 4xta
Go back to
Chlorine Binding Sites List in 4xta
Chlorine binding site 4 out
of 4 in the Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Mechanisms of Ppargamma Activation By Non-Steroidal Anti-Inflammatory Drugs within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl501
b:93.9
occ:1.00
|
CL4
|
B:DIF501
|
0.0
|
93.9
|
1.0
|
C4
|
B:DIF501
|
1.7
|
65.4
|
1.0
|
C5
|
B:DIF501
|
2.7
|
66.8
|
1.0
|
C3
|
B:DIF501
|
2.7
|
66.5
|
1.0
|
N1
|
B:DIF501
|
3.0
|
72.1
|
1.0
|
O2
|
B:DIF501
|
3.0
|
78.9
|
1.0
|
O
|
B:GLY284
|
3.7
|
99.7
|
1.0
|
C8
|
B:DIF501
|
3.9
|
79.7
|
1.0
|
C6
|
B:DIF501
|
4.0
|
66.6
|
1.0
|
C2
|
B:DIF501
|
4.0
|
63.4
|
1.0
|
C
|
B:GLY284
|
4.0
|
96.4
|
1.0
|
CG
|
B:ARG288
|
4.0
|
79.7
|
1.0
|
CG2
|
B:ILE341
|
4.1
|
68.4
|
1.0
|
CB
|
B:ILE341
|
4.1
|
73.8
|
1.0
|
C14
|
B:DIF501
|
4.2
|
74.2
|
1.0
|
CB
|
B:ARG288
|
4.2
|
77.0
|
1.0
|
N
|
B:CYS285
|
4.5
|
89.9
|
1.0
|
C9
|
B:DIF501
|
4.5
|
82.6
|
1.0
|
C1
|
B:DIF501
|
4.5
|
64.1
|
1.0
|
CA
|
B:GLY284
|
4.7
|
0.3
|
1.0
|
CD1
|
B:ILE341
|
4.7
|
83.9
|
1.0
|
CA
|
B:CYS285
|
4.7
|
90.2
|
1.0
|
C7
|
B:DIF501
|
4.8
|
82.0
|
1.0
|
C13
|
B:DIF501
|
5.0
|
78.0
|
1.0
|
CG1
|
B:ILE341
|
5.0
|
75.2
|
1.0
|
|
Reference:
A.C.Puhl,
F.A.Milton,
A.Cvoro,
D.H.Sieglaff,
J.C.Campos,
A.Bernardes,
C.S.Filgueira,
J.L.Lindemann,
T.Deng,
F.A.Neves,
I.Polikarpov,
P.Webb.
Mechanisms of Peroxisome Proliferator Activated Receptor Gamma Regulation By Non-Steroidal Anti-Inflammatory Drugs. Nucl Recept Signal V. 13 E004 2015.
ISSN: ISSN 1550-7629
PubMed: 26445566
DOI: 10.1621/NRS.13004
Page generated: Fri Jul 26 03:39:47 2024
|